EQT Sells Karo Healthcare to KKR

EQT VIII Sells Galderma Group AG Shares to L'Oréal S.A.

December 8, 2025

Healthcare Services

An affiliate of EQT VIII has signed an agreement to sell approximately 24 million shares in Galderma Group AG to L'Oréal S.A. The transaction is subject to customary regulatory approvals, and the premium was not disclosed.

EQT Infrastructure to Acquire KJ Environment in South Korea

August 16, 2024

Environmental Services

EQT Infrastructure VI has entered into a definitive agreement to acquire KJ Environment and affiliated companies to build an end-to-end waste treatment platform in South Korea focused on plastic recycling and waste-to-energy. The platform will leverage assets in the Greater Seoul Metropolitan Area and is intended to support a scaled and diversified circular economy infrastructure business. Closing is expected in Q4 2024, subject to customary conditions and approvals.

EQT Acquires Minority Stake in SHL Medical

January 3, 2020

Medical Devices

EQT VIII (EQT) has agreed to acquire a minority stake in SHL Medical, a Switzerland-headquartered manufacturer of advanced drug delivery devices including autoinjectors. The investment will support SHL's next phase of growth, innovation and digitization while leveraging EQT's healthcare expertise; the deal is subject to customary regulatory approvals.

EQT Acquires Recover Nordic

December 10, 2019

Industrial Services

EQT (via its EQT VIII fund) has entered into an agreement to acquire Recover Nordic from funds advised by Agilitas Private Equity. Recover Nordic is a Nordic market leader in property remediation and environmental services, headquartered in Oslo with over 90 branches and more than 2,100 employees; EQT said it will support the company’s digitalization, professionalization and continued M&A-led growth.

EQT Acquires Majority Stake in Ellab from IK Investment Partners

August 7, 2019

Medical Devices

EQT Mid Market Europe has agreed to acquire a majority interest in Ellab A/S from the IK VIII Fund (advised by IK Investment Partners). EQT will partner with Ellab's management, which will retain a minority stake, to accelerate global growth by expanding R&D, enhancing the go-to-market model in the US and Europe, and growing the company's as-a-service offerings.

Karo Pharma Acquires Trimb Healthcare from Avista Capital Partners

June 25, 2019

Pharmaceuticals

Karo Pharma AB (publ) has signed a definitive agreement to acquire Trimb Healthcare from Avista Capital Partners for SEK 3.4 billion. Trimb, a Stockholm‑based consumer healthcare company with ~90 employees and a portfolio of OTC brands, will expand Karo Pharma's geographic presence, distribution channels and product offerings in the Nordic and Northern European consumer health market.